Bokf, Na Tandem Diabetes Care Inc Transaction History

Bokf, Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$35.21 - $47.3 $2,323 - $3,121	66 New	66 $2,000
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $118,071 - $189,266	5,345 Added 28.94%	23,817 $843,000
Q4 2023 Feb 14, 2024	SELL	$14.28 - $31.03 $56,291 - $122,320	-3,942 Reduced 17.59%	18,472 $546,000
Q3 2023 Nov 14, 2023	BUY	$19.33 - $36.22 $433,262 - $811,835	22,414 New	22,414 $465,000
Q1 2023 May 11, 2023	BUY	$35.86 - $46.5 $433,583 - $562,231	12,091 New	12,091 $491,000

346

70.9M

3.11M

181K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.17B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.